Premetastatic niche: ready for new therapeutic interventions?

被引:28
作者
Zoccoli, Alice [1 ]
Iuliani, Michele [1 ]
Pantano, Francesco [1 ]
Imperatori, Marco [1 ]
Intagliata, Salvatore [1 ]
Vincenzi, Bruno [1 ]
Marchetti, Paolo [1 ,2 ]
Papapietro, Nicola [4 ]
Denaro, Vincenzo [4 ]
Tonini, Giuseppe [1 ]
Santini, Daniele [1 ,3 ]
机构
[1] Campus Biomed Univ, Dept Med Oncol, Rome, Italy
[2] St Andrea Hosp, Dept Med Oncol, Rome, Italy
[3] Univ Campus Biomed, I-00128 Rome, Italy
[4] Campus Biomed Univ, Dept Orthopaed & Trauma Surg, Rome, Italy
关键词
bone marrow derived cells (BMDC); cancer stem-like cells (CSC); chemokine; integrin; premetastatic niche RANK/RANKL; BREAST-CANCER METASTASIS; EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR-ASSOCIATED MACROPHAGES; M1 TRANSCRIPTION FACTOR; NF-KAPPA-B; BONE METASTASIS; LYSYL OXIDASE; OSTEOCLAST PRECURSORS; MESSENGER-RNA; CELL ADHESION;
D O I
10.1517/14728222.2012.656092
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
Introduction: Bone marrow-derived cells (BMDC) localize in premetastatic niche through chemokines and integrins signals and establish clusters that precede the arrival of even single metastatic tumor cell at distant site. CSCs demonstrate an increased metastatic propensity and would seem likely candidates for the acquisition of migratory capabilities and propagation of heterogeneous tumor cell populations to different target organs. Sonic Hedgehog (SHH), FOXM1 and Notch pathways and signaling molecules such as integrin and chemokine could dictate their fate. Areas covered: In this review, the molecular mechanisms of premetastatic niche onset are summarized. Expert opinion: Premetastatic niche is defined as a fertile microenvironment that forms in metastatic target organ and facilitates the invasion, survival and/or proliferation of metastatic tumor cells, providing a novel mechanism for the promotion of metastasis. Drugs targeting premetastatic niche could represent a new promising therapeutic approach in the treatment of bone metastases.
引用
收藏
页码:S119 / S129
页数:11
相关论文
共 92 条
[1]
Abraham BK, 2005, CLIN CANCER RES, V11, P1154
[2]
Prospective identification of tumorigenic breast cancer cells [J].
Al-Hajj, M ;
Wicha, MS ;
Benito-Hernandez, A ;
Morrison, SJ ;
Clarke, MF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (07) :3983-3988
[3]
Notch signaling: Cell fate control and signal integration in development [J].
Artavanis-Tsakonas, S ;
Rand, MD ;
Lake, RJ .
SCIENCE, 1999, 284 (5415) :770-776
[4]
Cilengitide inhibits progression of experimental breast cancer bone metastases as imaged noninvasively using VCT, MRI and DCE-MRI in a longitudinal in vivo study [J].
Baeuerle, Tobias ;
Komljenovic, Dorde ;
Merz, Maximilian ;
Berger, Martin R. ;
Goodman, Simon L. ;
Semmler, Wolfhard .
INTERNATIONAL JOURNAL OF CANCER, 2011, 128 (10) :2453-2462
[5]
Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes [J].
Baj-Krzyworzeka, M ;
Szatanek, R ;
Weglarczyk, K ;
Baran, J ;
Urbanowicz, B ;
Branski, P ;
Ratajczak, MZ ;
Zembala, M .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2006, 55 (07) :808-818
[6]
Transitions between epithelial and mesenchymal states in development and disease [J].
Baum, Buzz ;
Settleman, Jeffrey ;
Quinlan, Margaret P. .
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2008, 19 (03) :294-308
[7]
Tight correlation between expression of the Forkhead transcription factor FOXM1 and HER2 in human breast cancer [J].
Bektas, Nuran ;
ten Haaf, Anette ;
Veeck, Juergen ;
Wild, Peter Johannes ;
Luescher-Firzlaff, Juliane ;
Hartmann, Arndt ;
Knuechel, Ruth ;
Dahl, Edgar .
BMC CANCER, 2008, 8 (1)
[8]
A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-κB and enhanced IRF-3/STAT1 activation) [J].
Biswas, SK ;
Gangi, L ;
Paul, S ;
Schioppa, T ;
Saccani, A ;
Sironi, M ;
Bottazzi, B ;
Doni, A ;
Vincenzo, B ;
Pasqualini, F ;
Vago, L ;
Nebuloni, M ;
Mantovani, A ;
Sica, A .
BLOOD, 2006, 107 (05) :2112-2122
[9]
FoxM1 Mediates Resistance to Herceptin and Paclitaxel [J].
Carr, Janai R. ;
Park, Hyun Jung ;
Wang, Zebin ;
Kiefer, Megan M. ;
Raychaudhuri, Pradip .
CANCER RESEARCH, 2010, 70 (12) :5054-5063
[10]
Breast Cancer Cell Lines Contain Functional Cancer Stem Cells with Metastatic Capacity and a Distinct Molecular Signature [J].
Charafe-Jauffret, Emmanuelle ;
Ginestier, Christophe ;
Iovino, Flora ;
Wicinski, Julien ;
Cervera, Nathalie ;
Finetti, Pascal ;
Hur, Min-Hee ;
Diebel, Mark E. ;
Monville, Florence ;
Dutcher, Julie ;
Brown, Marty ;
Viens, Patrice ;
Xerri, Luc ;
Bertucci, Francois ;
Stassi, Giorgio ;
Dontu, Gabriela ;
Birnbaum, Daniel ;
Wicha, Max S. .
CANCER RESEARCH, 2009, 69 (04) :1302-1313